Mining Database for the Clinical Significance and Prognostic Value of ESRP1 in Cutaneous Malignant Melanoma

Abstract EN

Background.

Epithelial splicing regulatory protein 1 (ESRP1) has been described as an RNA-binding protein involved in cancer development.

However, the expression and regulatory network of ESRP1 in cutaneous malignant melanoma (CMM) remain unclear.

Methods.

From the sequencing data of 103 CMM samples in The Cancer Genome Atlas database, the expression level of ESRP1 and its correlation with the clinicopathological characteristics were analyzed using the Oncomine 4.5, Gene Expression Profiling Interactive Analysis (GEPIA), and UALCAN tools, while LinkedOmics was used to identify differential gene expression with ESRP1 and to analyze Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways.

Gene enrichment analysis examined target networks of kinases, miRNAs, and transcription factors.

Finally, TIMER was used to analyze the relationship between ESRP1 and tumor immune cell infiltration.

Results.

We found that ESRP1 was lowly expressed in CMM tissues, and a low level of ESRP1 expression correlated with better overall survival.

Expression of this gene was linked to functional networks involving the condensed chromosomes, epidermal development, and translation initiation.

Functional network analysis suggested that ESRP1 regulated ribosome metabolism, drug metabolism, and chemical carcinogenesis via pathways involving several cancer-related kinases, miRNAs, and transcription factors.

Furthermore, our results suggested that ESRP1 played an important role in regulating tumor-associated macrophage polarization, dendritic cell infiltration, Treg cells, and T cell exhaustion.

Conclusion.

Our study demonstrates ESRP1 expression, prognostic value, and potential regulatory networks in CMM, thereby shedding light on the clinical significance of ESRP1, and provides a novel biomarker for determining prognosis and immune infiltration in CMM.